Our goal at JWM Neurology is to help diagnose, treat, maintain and improve the lives patients who have suspected or confirmed multiple sclerosis.
All of our neurologists diagnose and treat patients who have multiple sclerosis as well as all types of neurological conditions and sleep disorders.
At the JWM Neurology Center For Multiple Sclerosis:
Over the past several years, our practice has become very active in clinical research. Through the work of neurologist Craig E. Herrman, MD, and his research staff, we have a dedicated JWM Research Division that offers numerous clinical trials for neurological conditions. Regardless of the type of MS that patients have, there are various trials available. Patients who do not currently qualify for one of our trials will be given the option to be put on a list for future opportunities.
JWM Neurology has several studies which are ongoing at all times. These encompass patients with not only relapsing remitting multiple sclerosis but also those with a first clinical event – or even those with a more progressive course of the disease. Studies range from new disease-modifying agents to medications that will improve the everyday symptoms seen in MS. Kristina Cleveland, (our clinical research manager) along with her staff, is dedicated to patient care and continuing to expand our JWM Neurology research opportunities.
The treatment of multiple sclerosis has become increasingly challenging over the past several years. There are multiple treatment options currently available in the general market and in research studies as well as those currently awaiting FDA approval. Physicians treating MS will need to be able to balance the use of reliable "older" medicines with those coming to market.
It is an exciting time in the field of multiple sclerosis. Injections, oral medications, monthly infusions and even yearly infusions are potential options. However, with each mode of therapy there are clear drawbacks. Through the collective expertise of our physicians at JWM Neurology, we are able to educate patients and make informed, joint decisions on the best treatment to pursue. Each patient will likely be different, and the treatment will not only differ based on potential side effects, but also on lifestyle and the particular variety of multiple sclerosis.
Craig E. Herrman, M.D.
Craig E. Herrman, MD, is from Richmond, Indiana. He finished high school at Richmond High then pursued his premedical education at Purdue. He graduated with a BS with high distinction and was accepted to the Indiana University School of Medicine. There he was elected to Alpha Omega Alpha which recognizes those students in the top of the class with emphasis on education and social endeavors. After medical school, he trained at the University of Rochester in upstate New York. He worked under several multiple sclerosis specialists and completed a fellowship with special training in EMG and EEG.
Dr. Herrman has particular interest in botulinum toxin (Botox®) for spasticity, and administers these injections. In addition to seeing patients with multiple sclerosis, Dr Herrman continues to spend time seeing general neurology inpatients and outpatients and performs/interprets EMGs and EEGs.
Patients with a first diagnosis of multiple sclerosis or suspected multiple sclerosis have many questions. The National Multiple Sclerosis Society has a very informative website which answers many of those questions (see the “Q&A” section on their homepage).